AbbVie
ABBV
#29
Rank
S$627.12 B
Marketcap
S$354.88
Share price
1.68%
Change (1 day)
18.13%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): S$11.21 Billion

According to AbbVie's latest financial reports the company's current earnings are S$64.38 Billion. In 2025 the company made an earning of S$8.45 Billion, an increase over its 2024 earnings that were of S$4.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$11.21 B32.72%
2025 S$8.45 B77.53%
2024 S$4.76 B-40.54%
2023 S$8.00 B-53.62%
2022 S$17.26 B3.76%
2021 S$16.64 B282.25%
2020 S$4.35 B-59.67%
2019 S$10.79 B62.13%
2018 S$6.65 B-32.74%
2017 S$9.89 B-1.99%
2016 S$10.10 B18.65%
2015 S$8.51 B180.5%
2014 S$3.03 B-55.57%
2013 S$6.83 B-6.86%
2012 S$7.33 B56.05%
2011 S$4.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.84 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$43.04 B 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.17 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.51 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$15.25 B 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.36 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$10.10 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.04 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA